Article Details

Q32 Bio finishes enrollment for eczema drug trial - Investing.com

Retrieved on: 2024-07-09 16:16:48

Tags for this article:

Click the tags to see associated articles and topics

Q32 Bio finishes enrollment for eczema drug trial - Investing.com. View article details on hiswai:

Excerpt

(NASDAQ: QTTB), a biotechnology firm engaged in developing therapeutic solutions for immune system balance, announced the completion of patient ...

Article found on: www.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up